NCT04214652View on ClinicalTrials.gov

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

March 18, 2021

Study Completion Date

March 18, 2021

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-126 Gel

IDP-126 Gel applied topically to the face once daily for 12 weeks.

DRUG

IDP-126 Vehicle Gel

IDP-126 Vehicle Gel applied topically to the face once daily for 12 weeks.

Trial Locations (13)

10022

Bausch Site 206, New York

21350

Bausch Site 202, Brighton

29190

Bausch Site 204, Johnston

33406

Bausch Site 207, West Palm Beach

40241

Bausch Site 209, Louisville

48202

Bausch Site 212, Detroit

72758

Bausch Site 205, Rogers

83704

Bausch Site 208, Boise

90266

Bausch Site 201, Manhattan Beach

97030

Bausch Site 203, Gresham

R3M 3Z4

Bausch Site 213, Winnipeg

L6J 7W5

Bausch Site 210, Oakville

K9J 5K2

Bausch Site 211, Peterborough

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT04214652 - Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter